View in EDS HTML Full Text PDF Full Text

Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.

Saved in:
Bibliographic Details
Title: Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
Authors: Hobor S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Hiley CT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK., Skrzypski M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.; Department of Oncology and Radiotherapy, Medical University of Gdańsk, ul. Mariana Smoluchowskiego 17, 80-214, Gdańsk, Poland., Frankell AM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Watkins TBK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Markovets A; Oncology Data Science, Oncology R&D, AstraZeneca, Boston, MA, USA., Dry JR; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Brown AP; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., van der Aart J; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., van den Bos H; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Spierings D; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Oukrif D; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK., Novelli M; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK., Chakrabarti T; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Rabinowitz AH; Furlong Laboratory, EMBL Meyerhofstraße 1, 69117, Heidelberg, Germany., Ait Hassou L; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Litière S; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK., Kerr DL; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Tan L; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Kelly G; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK., Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK., Renshaw MJ; Advanced Light Microscopy, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Venkatesan S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Huebner A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Martínez-Ruiz C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Black JRM; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Wu W; Department of Medicine, University of California, San Francisco, CA, 94158, USA., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Chmielecki J; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Barrett C; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA., Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Chew SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Blakely CM; Department of Medicine, University of California, San Francisco, CA, 94158, USA., de Bruin EC; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK., Foijer F; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands., Vousden KH; p53 and Metabolism Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Bivona TG; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, USA., Hynds RE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. n.kanu@ucl.ac.uk., Zaccaria S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. s.zaccaria@ucl.ac.uk.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Eva.Gronroos@crick.ac.uk., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Charles.Swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK. Charles.Swanton@crick.ac.uk.
Corporate Authors: TRACERx consortium
Source: Nature communications [Nat Commun] 2024 Jun 13; Vol. 15 (1), pp. 4871. Date of Electronic Publication: 2024 Jun 13.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38871738
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Hobor+S%22">Hobor S</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Al+Bakir+M%22">Al Bakir M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Hiley+CT%22">Hiley CT</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.<br /><searchLink fieldCode="AU" term="%22Skrzypski+M%22">Skrzypski M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK.; Department of Oncology and Radiotherapy, Medical University of Gdańsk, ul. Mariana Smoluchowskiego 17, 80-214, Gdańsk, Poland.<br /><searchLink fieldCode="AU" term="%22Frankell+AM%22">Frankell AM</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.<br /><searchLink fieldCode="AU" term="%22Bakker+B%22">Bakker B</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Watkins+TBK%22">Watkins TBK</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Markovets+A%22">Markovets A</searchLink>; Oncology Data Science, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Dry+JR%22">Dry JR</searchLink>; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Brown+AP%22">Brown AP</searchLink>; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22van+der+Aart+J%22">van der Aart J</searchLink>; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22van+den+Bos+H%22">van den Bos H</searchLink>; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Spierings+D%22">Spierings D</searchLink>; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oukrif+D%22">Oukrif D</searchLink>; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK.<br /><searchLink fieldCode="AU" term="%22Novelli+M%22">Novelli M</searchLink>; Research Department of Pathology, University College London Medical School, University Street, London, WC1E 6JJ, UK.<br /><searchLink fieldCode="AU" term="%22Chakrabarti+T%22">Chakrabarti T</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Rabinowitz+AH%22">Rabinowitz AH</searchLink>; Furlong Laboratory, EMBL Meyerhofstraße 1, 69117, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Ait+Hassou+L%22">Ait Hassou L</searchLink>; European Organization for Research and Treatment of Cancer, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Litière+S%22">Litière S</searchLink>; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Kerr+DL%22">Kerr DL</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Tan+L%22">Tan L</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Kelly+G%22">Kelly G</searchLink>; Bioinformatics & Biostatistics; Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Moore+DA%22">Moore DA</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Department of Cellular Pathology, University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Renshaw+MJ%22">Renshaw MJ</searchLink>; Advanced Light Microscopy, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Venkatesan+S%22">Venkatesan S</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Hill+W%22">Hill W</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Huebner+A%22">Huebner A</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Martínez-Ruiz+C%22">Martínez-Ruiz C</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Black+JRM%22">Black JRM</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22Angelova+M%22">Angelova M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22McGranahan+N%22">McGranahan N</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.; Cancer Genome Evolution Research Group, Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Downward+J%22">Downward J</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Chmielecki+J%22">Chmielecki J</searchLink>; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Barrett+C%22">Barrett C</searchLink>; Late Development, Oncology R&D, AstraZeneca, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Litchfield+K%22">Litchfield K</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Chew+SK%22">Chew SK</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.<br /><searchLink fieldCode="AU" term="%22Blakely+CM%22">Blakely CM</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.<br /><searchLink fieldCode="AU" term="%22de+Bruin+EC%22">de Bruin EC</searchLink>; Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Foijer+F%22">Foijer F</searchLink>; European Research Institute for the Biology of Ageing, University of Groningen, University Medical Center Groningen, A. Deusinglaan 1, Groningen, 9713, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Vousden+KH%22">Vousden KH</searchLink>; p53 and Metabolism Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.<br /><searchLink fieldCode="AU" term="%22Bivona+TG%22">Bivona TG</searchLink>; Department of Medicine, University of California, San Francisco, CA, 94158, USA.; Chan-Zuckerberg Biohub, San Francisco, USA.<br /><searchLink fieldCode="AU" term="%22Hynds+RE%22">Hynds RE</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.<br /><searchLink fieldCode="AU" term="%22Kanu+N%22">Kanu N</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. n.kanu@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Zaccaria+S%22">Zaccaria S</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. s.zaccaria@ucl.ac.uk.; Computational Cancer Genomics Research Group, University College London Cancer Institute, London, UK. s.zaccaria@ucl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Grönroos+E%22">Grönroos E</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Eva.Gronroos@crick.ac.uk.<br /><searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. Charles.Swanton@crick.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK. Charles.Swanton@crick.ac.uk.; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK. Charles.Swanton@crick.ac.uk.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22TRACERx+consortium%22">TRACERx consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 Jun 13; Vol. 15 (1), pp. 4871. <i>Date of Electronic Publication: </i>2024 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38871738
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-47606-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4871
    Titles:
      – TitleFull: Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hobor S
      – PersonEntity:
          Name:
            NameFull: Al Bakir M
      – PersonEntity:
          Name:
            NameFull: Hiley CT
      – PersonEntity:
          Name:
            NameFull: Skrzypski M
      – PersonEntity:
          Name:
            NameFull: Frankell AM
      – PersonEntity:
          Name:
            NameFull: Bakker B
      – PersonEntity:
          Name:
            NameFull: Watkins TBK
      – PersonEntity:
          Name:
            NameFull: Markovets A
      – PersonEntity:
          Name:
            NameFull: Dry JR
      – PersonEntity:
          Name:
            NameFull: Brown AP
      – PersonEntity:
          Name:
            NameFull: van der Aart J
      – PersonEntity:
          Name:
            NameFull: van den Bos H
      – PersonEntity:
          Name:
            NameFull: Spierings D
      – PersonEntity:
          Name:
            NameFull: Oukrif D
      – PersonEntity:
          Name:
            NameFull: Novelli M
      – PersonEntity:
          Name:
            NameFull: Chakrabarti T
      – PersonEntity:
          Name:
            NameFull: Rabinowitz AH
      – PersonEntity:
          Name:
            NameFull: Ait Hassou L
      – PersonEntity:
          Name:
            NameFull: Litière S
      – PersonEntity:
          Name:
            NameFull: Kerr DL
      – PersonEntity:
          Name:
            NameFull: Tan L
      – PersonEntity:
          Name:
            NameFull: Kelly G
      – PersonEntity:
          Name:
            NameFull: Moore DA
      – PersonEntity:
          Name:
            NameFull: Renshaw MJ
      – PersonEntity:
          Name:
            NameFull: Venkatesan S
      – PersonEntity:
          Name:
            NameFull: Hill W
      – PersonEntity:
          Name:
            NameFull: Huebner A
      – PersonEntity:
          Name:
            NameFull: Martínez-Ruiz C
      – PersonEntity:
          Name:
            NameFull: Black JRM
      – PersonEntity:
          Name:
            NameFull: Wu W
      – PersonEntity:
          Name:
            NameFull: Angelova M
      – PersonEntity:
          Name:
            NameFull: McGranahan N
      – PersonEntity:
          Name:
            NameFull: Downward J
      – PersonEntity:
          Name:
            NameFull: Chmielecki J
      – PersonEntity:
          Name:
            NameFull: Barrett C
      – PersonEntity:
          Name:
            NameFull: Litchfield K
      – PersonEntity:
          Name:
            NameFull: Chew SK
      – PersonEntity:
          Name:
            NameFull: Blakely CM
      – PersonEntity:
          Name:
            NameFull: de Bruin EC
      – PersonEntity:
          Name:
            NameFull: Foijer F
      – PersonEntity:
          Name:
            NameFull: Vousden KH
      – PersonEntity:
          Name:
            NameFull: Bivona TG
      – PersonEntity:
          Name:
            NameFull: Hynds RE
      – PersonEntity:
          Name:
            NameFull: Kanu N
      – PersonEntity:
          Name:
            NameFull: Zaccaria S
      – PersonEntity:
          Name:
            NameFull: Grönroos E
      – PersonEntity:
          Name:
            NameFull: Swanton C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 06
              Text: 2024 Jun 13
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1